{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:10:28Z","timestamp":1761898228224,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.clinre.2012.05.019","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T05:48:03Z","timestamp":1341467283000},"page":"402-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting miR-506 in primary biliary cirrhosis to support the HCO3\u2212 umbrella"],"prefix":"10.1016","volume":"36","author":[{"given":"Rui E.","family":"Castro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cec\u00edlia M.P.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2012.05.019_bib0005","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2012.05.019_bib0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2012.05.019_bib0015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.23783","article-title":"Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis","volume":"52","author":"Lleo","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2012.05.019_bib0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000324144","article-title":"Role of the anion exchanger 2 in the pathogenesis and treatment of primary biliary cirrhosis","volume":"29","author":"Medina","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.clinre.2012.05.019_bib0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.510250104","article-title":"Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis","volume":"25","author":"Medina","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2012.05.019_bib0030","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/jhep.2002.33634","article-title":"Defective regulation of cholangiocyte Cl-\/HCO3(-) and Na+\/H+ exchanger activities in primary biliary cirrhosis","volume":"35","author":"Melero","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2012.05.019_bib0035","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","article-title":"Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis","volume":"134","author":"Salas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2012.05.019_bib0040","doi-asserted-by":"crossref","unstructured":"Banales JM, Saez E, Uriz M, Sarvide S, Urribarri AD, Splinter P, et al. Upregulation of mir-506 leads to decreased AE2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology 2012 (Epub ahead of print).","DOI":"10.1016\/S0168-8278(12)60048-8"},{"key":"10.1016\/j.clinre.2012.05.019_bib0045","first-page":"695","article-title":"Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells","volume":"118","author":"Arenas","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2012.05.019_bib0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2012.05.019_bib0055","doi-asserted-by":"crossref","first-page":"G887","DOI":"10.1152\/ajpgi.00216.2010","article-title":"Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid","volume":"299","author":"Castro","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.clinre.2012.05.019_bib0060","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaut.2009.02.022","article-title":"Primary biliary cirrhosis is associated with altered hepatic microRNA expression","volume":"32","author":"Padgett","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2012.05.019_bib0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2008.06.006","article-title":"The unfinished business of primary biliary cirrhosis","volume":"49","author":"Selmi","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2012.05.019_bib0070","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00268-008-9836-x","article-title":"MicroRNAs: control and loss of control in human physiology and disease","volume":"33","author":"Li","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.clinre.2012.05.019_bib0075","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with \u2018antagomirs\u2019","volume":"438","author":"Krutzfeldt","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.clinre.2012.05.019_bib0080","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nature06783","article-title":"LNA-mediated microRNA silencing in non-human primates","volume":"452","author":"Elmen","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.clinre.2012.05.019_bib0085","doi-asserted-by":"crossref","first-page":"e28717","DOI":"10.1371\/journal.pone.0028717","article-title":"Ursodeoxycholic acid is conjugated with taurine to promote secretin-stimulated biliary hydrocholeresis in the normal rat","volume":"6","author":"Uriz","year":"2011","journal-title":"PLoS One"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740112001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740112001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:14:46Z","timestamp":1761894886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740112001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S2210740112001805"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2012.05.019","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting miR-506 in primary biliary cirrhosis to support the HCO3\u2212 umbrella","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2012.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}